This list may not reflect recent changes. List of largest biomedical companies by revenue - Wikipedia List of pharmaceutical companies - Wikipedia Eli Lilly announced a revenue increase of a healthy 16% on April 27th, 7% excluding the $810.1 million brought in by COVID-19 antibodies. Honeywell International is a technology and manufacturing company that offers energy, safety, and security solutions and technologies. Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs. Most Innovative Companies. SinoVeda Canada develops high quality nutraceuticals and prescription pharmaceuticals from botanical sources. This boosts Roches own portfolio, which includes the Elecsys IL-6 test and Elecsys Anti-SARS-CoV-2 antibody test. While Moderna is not expected to report Q1 earnings until May 6, Zacks Investment Research estimates that the mRNA vaccine king will finish the quarter trading at $2.64 per share an astronomical catapult from the reported $-0.35 in Q1, 2020 almost entirely the product of its mRNA-1273 vaccine for COVID-19 which won Emergency Use Approval in November. Elsewhere on the therapeutic spectrum, checkpoint inhibitor Libtayo (cemiplimab), which Sanofi co-markets with Regeneron Pharmaceuticals, performed so well in its phase III trial in cervical cancer, the trial was halted early. As Sanofi continues to work with partner, GSK, to refine its adjuvanted recombinant protein-based COVID-19 vaccine candidate, it is hoping for positive results from a phase II study meant to finalize a formulation that is effective for all adults. "2022 ranking of top 10 U.S. biotech and pharmaceutical companies based on total revenue (in billion U.S. The best of the best: the portal for top lists & rankings: Strategy and business building for the data-driven economy: Industry-specific and extensively researched technical data (partially from exclusive partnerships). Diabetes drug, Ozempic injection, won the year for Novo in 2020, bringing in $3.4 billion in biopharma companies sales. Available: https://www.statista.com/statistics/257436/top-global-biotech-and-pharmaceutical-companies-based-on-revenue/, 2022 ranking of top 10 U.S. biotech and pharmaceutical companies based on total revenue, Immediate access to statistics, forecasts & reports, World pharmaceutical market distribution by submarket 2014-2022, Top global pharmaceutical markets: growth rate 2018-2021, Leading therapy areas for U.S. drug spending 2020, U.S. top prescribed drugs based on sales 2021, Top pharma products by prescriptions U.S. 2020, Pharmaceutical channel distribution by U.S. spending 2017-2019, U.S. biopharmaceutical export volume 2002-2021, 2022 list of top U.S. biotech and pharmaceutical companies based on revenue, Pharmaceutical corporations by U.S. revenue 2021, Johnson & Johnson's total sales 2005-2022, Research and development expenditure: U.S. pharmaceutical industry 1995-2021, U.S. pharma industry R&D spending as a percent of total revenues 1990-2021, Pharmaceuticals: cost of drug development in the U.S. since 1975, Number of novel drugs approved annually by CDER 2008-2022, Number of orphan designations accepted in the U.S. 2003-2022, U.S. sales of new brand medicines 2012-2021, R&D expenditure per employee in U.S. sectors 2003-2017, Spending change on branded and generic medicines in the U.S. 2014-2021, U.S. brand and generic prescription drug spending 2017-2021, Branded vs. generic U.S. drug prescriptions dispensed 2005-2021, Savings through generic drug usage in the U.S. 2008-2021, Sales share at risk of pharmaceuticals due to patent expiries U.S. 2022, Share of U.S. people who had a favorable view of pharmaceutical companies 2021, U.S. approval of pharma companies' COVID-19 vaccine development handling 2021, Share of U.S. adults who approve pharmaceutical companies' drug price handling 2021, Share of people who had a favorable view of Pfizer in U.S. 2021, Share of people who had a favorable view of Moderna in U.S. 2021, Share of people who had a favorable view of J&J in U.S. 2021, World pharmaceutical sales by region forecast 2026, Sales at risk of pharmaceuticals due to patent expiries U.S. 2022, Leading U.S. pharmaceutical products by revenue 2026, U.S. cannabinoid-based pharmaceuticals market size 2020-2029 projection, Top pharma and biotech companies by net sales growth in 2021, Top 10 global pharmaceutical companies by revenue 2022, Leading global pharmaceutical risers based on share price 2022, Global leading pharma and biotech companies by total revenue in 2017, Top pharmaceutical companies' SG&A to revenue rate 2021, Market cap of select pharma companies with strong pipeline 2017, Leading global pharmaceutical risers based on market capitalization 2022, M&A capacities - changes for the global pharma industry 2008-2015, Total equity of the Ipsen group 2014-2019, Top global generic pharmaceutical companies, by enterprise value 2016, Top global generic pharmaceutical companies 2015, by revenue, Top 10 - pharmaceutical companies based on revenue in 2006, Business risks at selected pharmaceutical companies 2011, Lease expenses of selected U.S. pharmaceutical companies 2011 and 2016, Astellas Pharma's revenue FY 2021, by region, Mexico: veterinary pharmaceutical laboratories 2018, by type, Financing pattern of drugs and pharmaceutical industry India 2020, by value, Relative Nifty price performance GSK India 2009-2018, Worldwide generic pharmaceutical M&A deal value 2007-2015, 2022 ranking of top 10 U.S. biotech and pharmaceutical companies based on total revenue (in billion U.S. dollars), Find your information in our database containing over 20,000 reports. List of Pharmaceutical Companies in United States - ICH GCP Isotechnika Pharma is a biopharmaceutical company engaged in discovering and producing immunomodulating therapeutics. Akshaya Bio Inc. (Akshaya) is a privately held development stage biotechnology company. Eli Lilly and Company is an american global pharmaceutical company founded in 1876 by Eli Lilly. Executives, confident in their potential, reportedly maintain projections of $15 billion in sales for the duo in 2025. This list may not reflect recent changes. Bristol-Myers Squibb is a large US pharmaceutical company that develops and distributes medicines in the categories of cancer, HIV, analgesics, antibiotics, and cardiology. Your IP: All Rights Reserved. World pharmaceutical sales 2020-2022 by region, Market share of the leading global pharmaceutical markets 2021, Top 50 pharmaceutical companies - Rx sales and R&D spending 2021, To download this statistic in XLS format you need a Statista Account, To download this statistic in PNG format you need a Statista Account, To download this statistic in PDF format you need a Statista Account. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence. AbbVie still lays claim to the worlds highest-grossing product in immunology giant Humira, with sales just under $20 billion in 2020, but much attention has been paid recently to the drugs looming biosimilars face-off (AbbVies patent expires in 2023) and the companys corresponding strategy to offset future losses. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year. 2022 list of top U.S. biotech and pharmaceutical companies - Statista Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. Biogen recently announced that SAGE-324, the investigational therapy it is developing with Sage Therapeutics, significantly reduced tremor score in a phase II study of adults with essential tremor. AbbVie's revenue 2010-2022. Much more than a one-trick pony, BioNTech has mRNA-based medicines in many oncological pursuits including melanoma, non-small cell lung cancer (NSCLC), ovarian and breast cancer at various stages of development. Available for Android and iOS devices. Overview and forecasts on trending topics, Industry and market insights and forecasts, Key figures and rankings about companies and products, Consumer and brand insights and preferences in various industries, Detailed information about political and social topics, All key figures about countries and regions, Market forecast and expert KPIs for 1000+ markets in 190+ countries & territories, Insights on consumer attitudes and behavior worldwide, Business information on 70m+ public and private companies, Detailed information for 35,000+ online stores and marketplaces. RS Therapeutics offers advanced compounding propellant-free foam, which is designed for topical delivery of diclofenac sodium. 2023 MJH Life Sciences and Pharmaceutical Executive. Pharmaceutical companies in Edmonton are primarily engaged in the research, development, manufacturing, and distribution of pharmaceutical products for the healthcare industry. Soliris, a first-in-class C5 complement inhibitor for rare paroxysmal nocturnal hemoglobinuria (PNH) is facing steep competition from Apellis Pharmaceuticals C3 drug pegcetacopla, which demonstrated superiority in a head-to-head comparison recently published by the New England Journal of Medicine (NEJM). Information includes company addresses, telephone numbers, stock quotes, links to corporate websites, lists of medicines, support and employment opportunities where applicable. As market cap numbers illustrated in 2020, overall growth during the pandemic was swayed significantly by COVID-related factors, but not in all cases. The top 10 generic drug makers by 2021 revenue - Fierce Pharma Vertex, which recently expanded its collaborative partnership with CRISPR Therapeutics, enjoyed a year-over-year Q1 revenue increase of 14%. Quest PharmaTech is a pharmaceutical company that is developing antibody-based immunotherapeutic products for cancer. Ceapro is into developing functionally active ingredients derived from oats and renewable plant resources for healthcare and cosmetic needs. It does not include biotechnology companies that are now owned by, or form a part of, larger pharmaceutical groups. GSK, still planning to split the organization into two next year, recently announced plans to sell its complete stake in respiratory drug partner Innoviva (a royalty management company) for about $392 million. List of largest biomedical companies by revenue, List of largest biomedical companies by market capitalization, "Pfizer Reports Record Full-Year 2022 Results", Pfizer Reports Fourth-Quarter and Full-Year 2021 Results, Pfizer Reports Fourth-Quarter and Full-Year 2017 Results Provides 2018 Financial Guidance, Johnson & Johnson Reports Q4 and Full-Year 2022 Results, Johnson & Johnson Reports Q4 and Full-Year 2021 Results, "Johnson & Johnson Reports 2019 Fourth-Quarter And Full Year Results:", "Johnson & Johnson Reports 2018 Fourth-Quarter Results", "Johnson & Johnson Reports 2017 Fourth-Quarter Results: - Johnson & Johnson", "Johnson & Johnson Reports 2016 Fourth-Quarter Results - Johnson & Johnson", "Johnson & Johnson Reports 2015 Fourth-Quarter Results", "Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results - Johnson & Johnson", "Johnson & Johnson Reports 2013 Fourth-Quarter and Full-Year Results - Johnson & Johnson", "Annual Results Announcement for the year ended 31 December 2022", All For Health Health For All: Annual Report 2020, "[Ad hoc announcement pursuant to Art. All rights reserved. At the same time, Deloitte, in its new ROI of R&D Report, found that, of the 1,210 trials impacted by the pandemic from March-November 2020, the vast majority (66%) had delayed starts or completions, and 8% were terminated or stopped before enrolling any patients. As a Premium user you get access to background information and details about the release of this statistic. Global sales from Abbotts COVID-19 rapid testing platforms, BinaxNOW, Panbio and ID NOW, accounted for roughly 1/5 of the total, reeling in $1.8 billion or a total $2.2 billion in this space. The pharma industry quickly took center stage when COVID-19 caught the world off guard early last year. These companies play a crucial role in improving the quality of life for patients by producing innovative and effective medicines, vaccines, and other medical products. For example, according to figures compiled by GlobalData, AbbVie, which doesnt have any notable COVID products, enjoyed the biggest year-over-year growth in market cap, at 44.4%, among the top 10 drugmakers with the largest market caps at the end of 2020. The strong results were led by superstar drugs, Soliris and Ultomiris. Disease areas include oncology, immunology, ophthalmology, metabolism and virology. Olympus is a surgical Products, Imaging founded in 1919. The company currently has 19 new compounds in Phase III clinical trials or filed for approval. An Evaluate Vantage analysis uncovered fifth-year sales potential of $21.5 billion for those drugs, numbers comparable to pre-pandemic years. The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. Amid Cipla's eventful year in 2021, the India-based pharma churned out healthy revenue growth and landed at No. Last week, Merck reported that sales had stayed almost exactly the same as Q1, 2020 of biopharma companies, helped in large part by the strong performance of KEYTRUDA. The company hopes to combat any losses with drugs like multiple sclerosis drug Zeposia, which received the first FDA approval after the Celgene merger, in March 2020. The company plans to announce Q1 2021 results on May 10. The 10 most innovative medicine and therapeutics companies of 2022 Pages in category "Pharmaceutical companies of the United States" The following 200 pages are in this category, out of approximately 210 total. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa. Open now 5221 Crabapple Link SW, Edmonton, T6X 2H6 (780) 266-7686 Pharmaceutical company MIRACARE Pharmacy Closed now 3921 106 St NW, Edmonton, T6J 2S3 (780) 244-4221 Pharmaceuticals, Pharmacy, Medical supply store Sinoveda Canada Inc. Closed now 4294-91A Street, Edmonton, T6E 5V2 (780) 466-0086 BMS enjoyed an astronomical 63% revenue boost, with sales totaling $42.5 billion in 2020 as the fruits of the Celgene megamerger began to emerge, making it one of the successful biopharma companies. The top 20 pharma companies by 2021 revenue | Fierce Pharma Including only companies with a headquarter in the United States. By Heather McKenzie. The data is again provided in partnership with life sciences market intelligence firm Evaluate Ltd, and also includes company R&D spending totals. Amid the rush to develop and deliver effective vaccines and drugs for COVID, demands on companies were many. Both were being studied for the treatment of pneumonia related to the coronavirus. This only compounded the companys COVID-19 woes after it shuttered its pandemic vaccine program in January due to poor responses in Phase I studies. Published: May 03, 2021 The single-shot vaccine brought in $100 million for the quarter. Pharm Execs latest listing of the top global biopharma sales producers captures the critical business and public health balancing act that was required in the Year of COVIDreinforcing the staying power of building brand value while championing medical innovation. TC Scientific is a research and development company that specializing in the synthetic chemistry. The agency is currently reviewing the request. Regeneron, of COVID-19 antibody cocktail fame, is another new household name and becoming one of the famous biopharma companies. Pearko Therapeutics provides pharmacological therapies to patients with cardiovascular disease through innovative technologies. Check out our related features as we update them for 2021 and new features as they become available: And click through the 2020 listings and learn essential information about the companies powering the global pharmaceutical industry (2021 listings are being posted periodically): Copyright 2023 WTWH Media LLC. Pembient uses advances in biotechnology to fabricate horn and other wildlife products to combat the threat to endangered species. Currently, you are using a shared account. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence. Statista. Some highlights of note from the remainder of our rankings include an unfamiliar name in the 19th spot, Viatris, the new company formed after Mylan officially merged with Pfizers Upjohn; Vertex Pharmaceuticals leaping 13 spots, from 39th to 26th, with Rx sales up 49%, driven by cystic fibrosis newcomer Trikafta ($3.9 billion in 2020 sales); Regeneron moving up three spots to 28th behind drug revenue growth of 15%; and Chinas Jiangsu Hengrui Medicine (38th) generating over $880 million more in Rx sales last year versus 2019. separated into two companies where Abbott focuses on medical products and Abbvie is a research-based biopharmaceutical company. AbbVie is hoping its next-generation drugs Skyrizi and Rinvoq will help fill the gap post-patent. We comply with the HONcode standard for trustworthy health information. to incorporate the statistic into your presentation at any time. Takedas Rx revenue fell 4.6% last year, but the Japanese drugmaker is hopeful of potential reinforcements in the years ahead. And tislelizumab will be manufactured in style at BeiGenes recently approved one million square foot plus state-of-the-art biologics facility in Guangzhou, China. While the COVID-19 pandemic has dominated and highlighted the industry for the past year, some companies have made significant progress against the copious other diseases that refuse to let up. You can email the site owner to let them know you were blocked. Edmonton has a vibrant pharmaceutical industry with several leading companies, including Merck, Pfizer, and Novartis, operating in the region. Radient Technologies engages in the extraction, purification, and isolation of naturally-derived compounds and ingredients. Abbvie was founded in 2013 and is headquartered in North Chicago, IL. The most important statistics. 53 LR] Roche reports good results in 2021", "Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results", "Merck Announces Fourth-Quarter and Full-Year 2021 Financial Results", "Merck Announces Fourth-Quarter and Full-Year 2019 Financial Results", "Merck Announces Fourth-Quarter and Full-Year 2018 Financial Results", "Merck posts mixed fourth-quarter results as Keytruda sales skyrocket", "AbbVie Reports Full-Year and Fourth-Quarter 2022 Financial Results", "AbbVie Reports Full-Year and Fourth-Quarter 2021 Financial Results", "AbbVie Reports Full-Year and Fourth-Quarter 2019 Financial Results", "AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results - AbbVie News Center", "Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021", https://www.biospace.com/article/releases/bristol-myers-squibb-reports-fourth-quarter-and-full-year-financial-results-for-2019/?s=79, "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results - BMS Newsroom", "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results", "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results - BMS Newsroom", "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2015 Financial Results - BMS Newsroom", "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2014 Financial Results - BMS Newsroom", "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2013 Financial Results - BMS Newsroom", "AstraZeneca PLC fourth quarter and full year results 2014", "AstraZeneca PLC fourth quarter and full year results 2013 - AstraZeneca", "Abbott reports fourth-quarter and full-year 2022 results", "Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast", "Abbott Reports Fourth-Quarter 2019 Results; Announces Strong Forecast for 2020", "Abbott Reports 2018 Results and Issues Strong Forecast for 2019", "Abbott Reports Fourth-Quarter 2017 Results", "Abbott Reports Fourth-Quarter 2016 Results", "Abbott Reports Fourth-Quarter 2015 Results", "Abbott Reports Fourth-Quarter 2014 Results", "Abbott Reports Fourth-Quarter and Full-Year 2013 Results", "Income statement: Year ended 31 December 2021", "GSK delivers sales, earnings and cash flow growth in 2018 - GSK", "Shanghai Pharmaceuticals 2022 Annual Results Announcement", "Takeda quarterly financial report for the year ended March 31, 2023", "Takeda Accelerates Transformation: Solid FY2019 Results, Confidence in FY2020 Growth Momentum", "Takeda Reports FY2018 Full Year Results and Issues FY2019 Guidance", "Takeda reports FY2017 full year results and issues FY2018 guidance", "Takeda Pharmaceutical Company Limited and its Subsidiaries Consolidated Financial Statements Under IFRSs and Independent Auditor's Report", "Lilly Reports Fourth-Quarter 2022 Financial Results", "Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition", "Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology", "Lilly Reports Fourth-Quarter and Full-Year 2016 Results (NYSE:LLY)", "Gilead Sciences Announces Fourth Quarter and Full Year 2022 Financial Results", "Gilead Sciences Announces Fourth Quarter and Full Year 2020 Financial Results", "Gilead Sciences Announces Fourth Quarter and Full Year 2019 Financial Results", "Gilead Sciences Announces Fourth Quarter and Full Year 2018 Financial Results", "Amgen Reports Fourth Quarter and Full Year 2022 Financial Results", Amgen Reports Fourth Quarter and Full Year 2021: Financial Results, "Amgen Reports Fourth Quarter and Full Year 2019 Financial Results", "Amgen Reports Fourth Quarter And Full Year 2017 Financial Results", "Boehringer Ingelheim Financial Report 2022", "Boehringer Ingelheim Summary Report 2021", "Boehringer Ingelheim Annual Report 2020", "Boehringer Ingelheim Annual Report 2019", "Boehringer Ingelheim Annual Report 2018", "Boehringer Ingelheim Annual Report 2017", "Novo Nordisk Financial report for the period 1 January 2022 to 31 December 2022", "Novo Nordisk's (NVO) CEO Lars Rebien Sorensen on Q4 2015 Results - Earnings Call Transcript", "Novo Nordisk's (NVO) CEO Lars Sorensen on Q4 2014 Results - Earnings Call Transcript", "Novo Nordisk A/S Management Discusses Q4 2013 Results - Earnings Call Transcript", "Siemens Healthineers Annual Report 2022", Combined Financial Statements for the fiscal years ended September 30, 2017, 2016 and 2015, "Moderna Reports Fourth Quarter and Fiscal Year 2022 Financial Results", "BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update", "BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Update", "BioNTech Announces Full Year 2020 Financial Results and Corporate Update", "GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results", "GE fourth quarter & full year 2021 performance: Financial results & company highlights", "General Electric Healthcare segment revenue 2008-2020", "Viatris Reports Strong Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance", "Viatris Reports Strong Fourth Quarter and Full-Year 2021 Financial Results", "Baxter Reports Fourth-Quarter and Full-Year 2022 Results", "Baxter Reports Fourth-Quarter and Full-Year 2021 Results", "Teva Reports Fourth Quarter and Full Year 2022 Financial Results", "Teva Reports Fourth Quarter and Full Year 2021 Financial Results", "Teva Reports Fourth Quarter and Full Year 2019 Financial Results", "Teva Reports 2017 Full Year and Fourth Quarter Financial Results", "Teva Reports Full Year and Fourth Quarter 2016 Financial Results", "Teva Reports Full Year 2015 and Fourth Quarter Financial Results", "Teva Reports Fourth Quarter and Full Year 2014 Results", "Teva Reports Fourth Quarter and Full Year 2013 Results", "Consolidated Financial Results for the Fiscal Year Ended December 31, 2022", "Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results", Regeneron Reports Fourth Quarter and Full Year 2021 Financial and Operating Results, "Biogen Reports Fourth Quarter and Full Year 2022 Results", "Biogen Q4 & Full Year 2019: Financial Results and Business Update", "Biogen Q4 & Full Year 2018: Financial Results and Business Update", "Biogen's Spinraza: Great Launch, Rough Ride", "Financial Results of Astellas for Fiscal Year 2021", For the Year Ended March 31, 2021 Annual Report 2021, "Astellas Pharma Inc.
Csulb Counseling Major, Articles L